Archives
-
Firefly Luciferase mRNA: Assay Workflows
2026-09-24
Build a reproducible luminescence workflow around a capped, 5-methoxyuridine-modified reporter—and distinguish delivery failure from changes in cell health. Practical pilot conditions, troubleshooting guidance, and a carefully bounded connection to oral RNA nanoparticle research help teams choose the right next experiment.
-
From Plant Stress Signaling to Luciferase Assays
2026-09-24
A mechanistic study of rapeseed shading tolerance illustrates how reporter assays can support evidence for molecular interactions—while also clarifying what luminescence can and cannot establish. This article connects that logic to D-Luciferin potassium salt, practical assay design, and translational decision-making.
-
NAT1–ENO1–Lactate Axis in Colorectal Cancer
2026-09-23
A 2026 MedComm study connects NAT1-dependent ENO1 acetylation to lactate production and TRAF6-mediated PD-L1 stabilization in colorectal cancer. The findings suggest that tumor metabolism can influence checkpoint protein stability and provide a mechanistic rationale for testing metabolic perturbation alongside immunotherapy, while leaving key translational questions unresolved.
-
Gemcitabine HCl: Mechanism and Tumor Study Workflow
2026-09-23
Gemcitabine HCl is a deoxycytidine analog that inhibits DNA synthesis through active nucleotide metabolites and DNA incorporation. Product-dossier benchmarks and MRI-guided pancreatic tumor studies support its use for mechanism-focused cytotoxicity testing and longitudinal preclinical research.
-
Firefly Luciferase mRNA: Assay Design Guide
2026-09-22
Firefly Luciferase mRNA (ARCA, 5-moUTP) is more than a luminescent reporter: it is a tool for separating transcript delivery, translation, and cellular function. This guide explains its molecular design, assay interpretation, and relevance to emerging mRNA formulation strategies.
-
Dextrose (D-glucose) for Immunometabolic Assays
2026-09-22
Build controlled hypoxia, tumor–immune co-culture, and glucose-response experiments with Dextrose (D-glucose) as a defined metabolic input. This workflow-focused guide connects reagent preparation, assay design, and troubleshooting to practical glucose metabolism research while preserving clear limits between evidence and laboratory recommendations.
-
ATP as a Lens on Mitochondrial Metabolism
2026-09-21
Adenosine Triphosphate (ATP) is more than a cellular energy currency: it is an interpretive variable for connecting mitochondrial proteostasis with metabolic phenotype. This article explains how the TCAIM–OGDH discovery should shape ATP handling, controls, and assay design.
-
GKT137831: Dual Nox1/Nox4 Inhibitor Workflows
2026-09-20
Build reproducible oxidative-stress assays with GKT137831, a dual NADPH oxidase Nox1/Nox4 inhibitor suited to vascular, fibrosis, and metabolic disease models. A membrane-focused ferroptosis study adds a practical lesson: pair reactive oxygen species measurements with late-stage plasma-membrane integrity endpoints rather than relying on one readout.
-
Cefazedone: From MIC Data to Translational Assays
2026-09-19
Cefazedone (Refosporen) is examined through a translational lens, connecting mechanism, MIC methodology, β-lactamase considerations, and pharmacodynamic exposure. This evidence-focused guide shows how to design more interpretable antibacterial testing in vitro rather than simply reproducing comparative rankings.
-
Tumor-Targeted T Cell Engineering in Cold Tumors
2026-09-18
He et al. developed P αCD3&LIGHT, a tumor-targeted plasmid that uses the TERT promoter to co-express LIGHT and membrane-anchored anti-CD3, thereby coordinating T cell recruitment, entry, activation, and persistence in immune-cold tumors. The strategy suppressed several solid tumor models and enhanced checkpoint inhibitor and CAR-T activity, while its translational relevance remains dependent on tumor targeting, delivery, and validation in clinically representative systems.
-
Isoliensinine, TRPV1–AMPK, and MAFLD Fibrosis
2026-09-18
A 2025 Journal of Future Foods study identifies a TRPV1–AMPK mechanism through which isoliensinine from Plumula Nelumbinis restores lipid droplets in hepatic stellate cells and attenuates fibrosis in metabolic associated fatty liver disease models. Its combination of complementary animal models, LX2-cell experiments, and molecular validation provides a mechanistic framework for studying lipid-droplet remodeling in fibrogenesis, while leaving important questions about clinical translation and pathway specificity unresolved.
-
LMO2–LDB1 Signaling in Acute Myeloid Leukemia
2026-09-17
The reference study identifies an LMO2/LDB1 protein complex as a functional driver of acute myeloid leukemia, rather than treating LMO2 only as a prognostic marker. By combining protein-interaction mapping, gene perturbation, transcriptomics, chromatin profiling, and rescue experiments, the work positions LDB1 as an essential co-regulator of leukemic cell proliferation and survival.
-
Energy Stress, AMPK, and Ferroptosis in Proteinopathies
2026-09-17
The reference study shows that energy stress activates an AMPK–ACC1 checkpoint that suppresses ferroptosis across neuronal proteinopathy models. Its combination of cellular, Caenorhabditis elegans, and 3xTg-AD mouse experiments links metabolic sensing to lipid peroxidation, neuronal injury, and disease-relevant behavioral outcomes.
-
HBsAg–TBK1 Crosstalk in Interferon and Autophagy
2026-09-16
The reference study identifies a mechanism by which hepatitis B surface antigen redirects TBK1 signaling away from IRF3-dependent type I interferon production and toward p62-associated autophagy. Its integrated cellular, animal, and patient-tissue analyses suggest that incomplete autophagy may support HBV persistence by weakening antiviral defense and blocking autophagic clearance.
-
Dorsomorphin (Compound C) for AMPK Research
2026-09-16
Dorsomorphin (Compound C) provides reversible control of AMPK while also enabling BMP/Smad pathway studies. This practical guide translates liver-fibrosis findings into cell-based workflows for macrophage polarization, hepatic stellate cell activation, autophagy regulation, and pathway-specific troubleshooting.